{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:09:32Z","timestamp":1791227372231,"version":"4.1.0"},"reference-count":17,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.usa.gov\/government-works"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Fluoroquinolones are important antimicrobial drugs used to treat human\n            <jats:named-content content-type=\"genus-species\">Salmonella<\/jats:named-content>\n            infections, and resistance is rare in the United States for isolates from human and animal sources. Recently, a number of\n            <jats:named-content content-type=\"genus-species\">Salmonella<\/jats:named-content>\n            isolates from swine cecal contents and retail pork products from National Antimicrobial Resistance Monitoring System (NARMS) surveillance exhibited decreased susceptibility to ciprofloxacin. We identified two\n            <jats:italic>qnrB19<\/jats:italic>\n            quinolone resistance plasmids that are predominantly responsible for this phenomenon and found them distributed among several\n            <jats:named-content content-type=\"genus-species\">Salmonella<\/jats:named-content>\n            serotypes isolated throughout the United States.\n          <\/jats:p>","DOI":"10.1128\/aac.01318-17","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:40:19Z","timestamp":1502152819000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":34,"title":["Identification of Plasmid-Mediated Quinolone Resistance in Salmonella Isolated from Swine Ceca and Retail Pork Chops in the United States"],"prefix":"10.1128","volume":"61","author":[{"given":"Gregory H.","family":"Tyson","sequence":"first","affiliation":[{"name":"U.S. Food and Drug Administration, Center for Veterinary Medicine, Office of Research, Laurel, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather P.","family":"Tate","sequence":"additional","affiliation":[{"name":"U.S. Food and Drug Administration, Center for Veterinary Medicine, Office of Research, Laurel, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Zhao","sequence":"additional","affiliation":[{"name":"U.S. Food and Drug Administration, Center for Veterinary Medicine, Office of Research, Laurel, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[{"name":"U.S. Food and Drug Administration, Center for Veterinary Medicine, Office of Research, Laurel, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Dessai","sequence":"additional","affiliation":[{"name":"U.S. Department of Agriculture, Food Safety and Inspection Service, Office of Public Health Science, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Simmons","sequence":"additional","affiliation":[{"name":"U.S. Department of Agriculture, Food Safety and Inspection Service, Office of Public Health Science, Athens, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"McDermott","sequence":"additional","affiliation":[{"name":"U.S. Food and Drug Administration, Center for Veterinary Medicine, Office of Research, Laurel, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6514a2"},{"key":"e_1_3_2_3_2","unstructured":"Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States 2013. https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/index.html."},{"key":"e_1_3_2_4_2","unstructured":"U.S. Food and Drug Administration. 2003. Guidance for industry 152: evaluating the safety of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health concern. https:\/\/www.fda.gov\/downloads\/AnimalVeterinary\/GuidanceComplianceEnforcement\/GuidanceforIndustry\/UCM052519.pdf."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00580-08"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.7.1621"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2016.09.001"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00016-09"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1611.100464"},{"key":"e_1_3_2_10_2","volume-title":"The National Antimicrobial Resistance Monitoring System for enteric bacteria (NARMS)","author":"U.S. Food and Drug Administration","year":"2016","unstructured":"U.S. Food and Drug Administration. 2016. 2014 NARMS integrated report. The National Antimicrobial Resistance Monitoring System for enteric bacteria (NARMS). U.S. Food and Drug Administration, Rockville, MD."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks261"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1347"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01160-09"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp383"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06036-11"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks024"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00866-10"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/zph.12318"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01318-17","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01318-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:48:13Z","timestamp":1645476493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01318-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1128\/AAC.01318-17"],"URL":"https:\/\/doi.org\/10.1128\/aac.01318-17","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"2017-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01318-17"}}